Adderall, Adderall XR Fact Sheet
ADHD (adults and children >3 years for IR, >6 years for XR); narcolepsy (adults and children >6 years).
- Supplied as:
- 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 20 mg, 30 mg tablets as Adderall (Teva) and generic.
- 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, 30 mg ER capsules as Adderall XR (Shire) and generic.
- C-II controlled substance.
- Each dose contains a mixture of salts (25% each): dextroamphetamine sulfate; dextroamphetamine saccharate; d-, l-amphetamine aspartate monohydrate; and d-, l-amphetamine sulfate (resulting in a 75:25 ratio of dextro and levo isomers of amphetamine).
- Rule of thumb for both preparations: initial dose should be 0.5 mg/kg but shoot for a target dose of 1.0 mg/kg–1.2 mg/kg.
- ADHD (children >3 years):
- IR: start at 2.5–5 mg BID, max of 40 mg/day divided BID.
- XR: start 5 mg–10 mg QAM, increase gradually to max of 30 mg/day, or 40 mg/day QAM in adolescents.
- ADHD (adults):
- IR: start at 5 QAM–BID, max of 40 mg/day divided BID.
- XR: start 20 mg QAM, increase to max of 60 mg/day QAM.
- May convert from IR to XR at same total daily dose, given QAM.
- Cost (for one month supply at 40 mg/day, priced Jan 2014):
- Mixed amphetamine and dextroamphetamine salts (generic): $55.58; $238.90 (XR)
- Adderall: $296.94 ; $459.39 (XR)
- Most common (most bothersome in bold): insomnia, headache, decreased appetite, abdominal pain, weight loss, agitation.
- Avoid use with MAOIs, antacids. Caution with pressors (additive effects).
- Metabolized primarily through CYP2D6; t ½: 9−14 hours. Duration of action: 6–8 hours (IR). 8–10 hours (XR).
- Adderall may provide more of a “kick” and therefore feel more immediately effective than methylphenidate preparations. Roughly twice as potent (per mg) as methylphenidate.
- XR may be swallowed whole or opened and sprinkled on applesauce. Use immediately; do not divide contents.
- Dextroamphetamine and mixed amphetamine salts are the only stimulants approved for children <6 years (approved for children >3 years).
Was briefly pulled from the market in Canada in 2005 because of cardiac concerns…then authorities changed their minds.
It is important to be familiar with a couple of the amphetamine products, ideally a short-acting one and a long-acting one for patients who don’t do well on methylphenidate-type stimulants.
Parts of our website are currently being worked on by our development team. You may not be able to access some content that you're used to being able to access. We appreciate your patience while we reorganize the site. (2.27.15)
The Carlat Psychiatry Report Medication Fact Book Is Available Now!
Earn CME Credit Instantly!
Not quite ready for a one-year subscription to The Carlat Psychiatry Report? Need CME credits on a particular topic or on a tight deadline?
Try our A la Carte CME! You can buy single or multiple credits of continuing education, without committing to a year-long newsletter subscription.
Already an A la Carte subscriber?